Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2887 (LINC02887) is a non-protein coding RNA gene classified as a long intergenic non-coding RNA (lincRNA), a subset of the long non-coding RNA (lncRNA) family[1][3]. LincRNAs are defined as autonomously transcribed non-coding RNAs longer than 200 nucleotides that do not overlap annotated protein-coding genes[3]. While lincRNAs such as LINC02887 are known to participate in chromatin remodeling, regulation of gene expression, and RNA stabilization, specific biological functions and disease associations for LINC02887 itself have not been characterized in the literature as of the knowledge cut-off date[3][1]. There are no drugs, mechanisms of drug action, or biomarkers currently linked to LINC02887, and it is not considered a direct therapeutic target[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2887 (LINC02887).